Page 82 - UCT2012 Health Sciences

Basic HTML Version

variants associated with systemic atherosclerosis and
coronary atherosclerotic burden but not with venous
thromboembolism. Journal of the American College of
Cardiology, 60(8): 722-729.
Hendrik, S.H., Sudano, I., Theus, G., Noll, G. and
Burnier, M. 2012. Target blood pressure attainment with
antihypertensive therapy in Swiss primary care. Blood
Pressure, 21(4): 211-219.
Herrmann, C., Salas, P.F., Cawthray, J.F., De Kock, C., O
Patrick, B., Smith, P.J., Adam, M.J. and Orvig, C. 2012.
1,1’-Disubstituted ferrocenyl carbohydrate chloroquine
conjugates as potential antimalarials. Organometallics, 31:
Herrmann, C., Salas, P.F., O Patrick, B., De Kock, C., Smith,
P.J., Adam, M.J. and Orvig, C. 2012. 1,2-Disubstituted
ferrocenyl carbohydrate chloroquine conjugates as
potential antimalarial agents. Dalton Transactions, 41:
Herrmann, C., Salas, P.F., O Patrick, B., De Kock, C., Smith,
P.J., Adam, M.J. and Orvig, C. 2012. Modular synthesis
of 1,2- and 1,1’-disubstituted ferrocenyl carbohydrate
chloroquine and mefloquine conjugates as potential
antimalarial agents. Organometallics, 31: 5748-5759.
Holgate, S.L., Rabie, H., Smith, P. and Cotton, M. 2012.
Trough lopinavir concentrations in preterm HIV-infected
infants. Pediatric Infectious Disease Journal, 31(6): 602-604.
Howard, A., Gasana, M., Getahun, H., Harries, A.D., Lawn,
S.D., Miller, B., Nelson, L., Sitienei, J. and Coggin, W.L.
2012. PEPFAR support for the scaling up of collaborative
TB/HIV activities. Jaids-Journal of Acquired Immune
Deficiency Syndromes, 60(3): S136-S144.
Hu, D., Barajas-Martinez, H., Medeiros-Domingo, A., Crotti,
L., Veltmann, C., Schimpf, R., Urrutia, J., Alday, A., Casis,
O., Pfeiffer, R., Burashnikov, E., Caceres, G., Tester, D.J.,
Wolpert, C., Borggrefe, M., Schwartz, P.J., Ackerman, M.J.
and Antzelevitch, C. 2012. A novel rare variant in SCN1Bb
linked to Brugada syndrome and SIDS by combined
modulation of Nav1.5 and Kv4.3 channel currents. Heart
Rhythm, 9(5): 760-769.
Huisamen, B., Dietrich, D., Bezuidenhout, N., Lopes, J., Flepisi,
B., Blackhurst, D.M. and Lochner, A. 2012. Early cardiovascular
changes occuring in diet-induced, obese insulin-resistant rats.
Molecular and Cellular Biochemistry, 368: 37-45.
Isaacs, T. 2012. Skin hypersensitivity reactions to
preservatives. Current Allergy & Clinical Immunology,
25(1): 41-45.
Ishikawa, T., Sato, A., Marcou, C.A., Tester, D.J., Ackerman,
M.J., Crotti, L., Schwartz, P.J., On, Y.K., Park, J.E., Nakamura,
K., Hiraoka, M., Nakazawa, K., Sakurada, H., Arimura, T.,
Makita, N. and Kimura, A. 2012. A novel disease gene for
Brugada syndrome: sarcolemmal membrane-associated
protein gene mutations impair intracellular trafficking of
hNav1.5. Circulation-Arrhythmia and Electrophysiology, 5:
1098 -1107.
Jabar, A., Wallis, L.A., Ruter, A. and Smith, W.P. 2012.
Modified Delphi study to determine optimal data elements
for inclusion in an emergency management database
system. African Journal of Emergency Medicine (AfJEM),
2: 13-19.
Jackson, A., Nussbaum, J.C., Phulusa, J., Namarika, D.,
Chikasema, M., Kanyemba, C., Jarvis, J.N., Jaffar, S.,
Hosseinipour, M., van der Horst, C. and Harrison, T. 2012. A
phase II randomized controlled trial adding oral flucytosine
to high - dose fluconazole, with short-course amphotericin
B, for cryptococcal meningitis. Aids, 26: 1363-1370.
James, R.W., Frias, M.A. and Lecour, S. 2012. Lipid-
induced modulation of protective signalling pathways in
cardiovascular disease: the role of high density lipoproteins.
Current Signal Transduction Therapy, 7(2): 96-103.
Jarvis, J.N., Meintjes, G., Rebe, K., Williams, G.M., Bicanic,
T., Williams, A., Schutz, C., Bekker, L., Wood, R. and
Harrison, T. 2012. Adjunctive interferon- immunotherapy for
the treatment of HIV-associated cryptococcal meningitis: a
randomized controlled trial. Aids, 26: 1105-1113.
Jones, E., Owen, P. and Rayner, B.L. 2012. The association of
the R563Q genotype of the ENaC with phenotypic variation
in Southern Africa. American Journal of Hypertension,
25(12): 1286-1291.
Jones, P.W., Singh, D., Bateman, E.D., Agusti, A., Lamarca,
R., de Miquel, G., Segarra, R., Caracta, C. and Gil, E.G.
2012. Efficacy and safety of twice-daily aclidinium bromide
in COPD patients: the ATTAIN study. European Respiratory
Journal, 40(4): 830-836.
Karthikeyan, G., Zuhlke, L., Engel, M.E., Rangarajan, S.,
Yusuf, S., Teo, K. and Mayosi, B.M. 2012. Rationale and
design of a global rheumatic heart disease registry: the
remedy study. American Heart Journal, 163: 535-540.
Kaze, F.F., Ashuntantang, G., Kengne, A.P., Hassan, A., Halle,
M.P. and Muna, W. 2012. Acute hemodialysis complications
in end-stage renal disease patients: the burden and
implications for the under-resourced Sub-Saharan African
health systems. Hemodialysis International, 16: 526-531.